Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Polar Capital Global Healthcare Trust Shares Slip as Sector Rotation Continues

Polar Capital Global Healthcare Trust PLC (LSE:PCGH) shares fell to 446.00p, down 4.00p, or 0.89%, according to the market data provided, as sentiment toward global healthcare equities softened.

Divya Sood | 14 August 2026

Oxford Biomedica Shares Slip Despite Gene Therapy Manufacturing Growth

Oxford Biomedica PLC (LSE:OXB) shares fell to 484.00p, down 3.50p, or 0.72%, according to the market data provided, a modest decline for the gene and cell therapyManufacturingspecialist.

Divya Sood | 14 August 2026

EDX Medical Group Stock Builds Bullish Pressure as Commercial Progress Strengthens Investor Optimism

EDX Medical Group develops diagnostic products and services intended to improve disease detection and support personalised treatment. Its principal areas include cancer, cardiovascular disease, infectious disease and broader health screening. The recent share-price rise appears to reflect renewed interest following product launches, NHS deployment …

Ankur Sharma | 14 August 2026

Can Diagnostic Demand Drive Spire Growth?

Spire Healthcare Group PLC (LSE:SPI)shares declined0.43%, a relatively small movement that does not necessarily indicate a significant deterioration in the company's fundamentals.

Divya Sood | 14 August 2026

Genflow Biosciences Share Price Rises as Sentiment Toward Its Gene-Therapy Pipeline Improves

Genflow Biosciences Plc is an AIM-listed biotechnology company developing gene therapies targeting age-related and metabolic diseases, built around licensed longevity-gene technology. The shares advanced strongly in the latest session, a move consistent with renewed investor interest in early-stage biotech names as sentiment toward the …

Ankur Sharma | 14 August 2026

OptiBiotix Health Share Price Builds Recovery Momentum as Sales Growth and Microbiome Commercialization Lift Optimism

OptiBiotix Health plc develops microbiome-based ingredients and consumer products focused on weight management, gut health and healthier sugar alternatives. Its main technologies include SlimBiome, WellBiome and SweetBiotix. The stock’s recent rise reflects improved order momentum, stronger margins and optimism that years of product development …

Ankur Sharma | 14 August 2026

Abingdon Health Share Price Builds Bullish Momentum as Growth and Profitability Progress Improve Sentiment

Abingdon Health plc is an international contract-development, manufacturing and regulatory-services provider specializing in rapid diagnostic tests and wider medical technology. Its integrated platform supports customers from product concept and assay development through regulatory approval and commercial production. The stock’s recent rise reflects stronger trading, …

Ankur Sharma | 14 August 2026

Hostelworld Share Price Builds Bullish Momentum as Social Travel Strategy and Revenue Growth Lift Optimism

Hostelworld Group plc operates a technology-led travel platform connecting budget-conscious travelers with hostels and other accommodation providers. The company is evolving from a specialist online booking agent into a broader social travel network incorporating traveler matching, event discovery and paid social access. The stock’s …

Ankur Sharma | 14 August 2026

Allergy Therapeutics Share Price Shows Recovery Momentum as Grassmuno Launch Strengthens Growth Outlook

Allergy Therapeutics plc is a commercial biotechnology company focused on diagnosing and treating allergic conditions through immunotherapy. Its portfolio includes treatments for pollen, venom and other allergies, alongside a development pipeline targeting significant unmet needs such as peanut allergy. The stock’s recent improvement reflects …

Ankur Sharma | 14 August 2026

Coiled Therapeutics Share Price Gains Bullish Momentum as Clinical Progress Strengthens Investor Optimism

Coiled Therapeutics develops small-molecule treatments designed to exploit specific biological dependencies in aggressive cancers. Its lead programme, AO-252, is a brain-penetrant oral inhibitor of TACC3, a protein involved in cancer-cell division, DNA-damage repair and survival. The stock’s recent rise appears to reflect growing confidence …

Ankur Sharma | 14 August 2026
Support

Hi! How can we help you today?

Loading…